(Q43787821)

26 November 2017

Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study (English)

1 reference

26 November 2017

10

1 reference

26 November 2017

Boubaker K

1

1 reference

26 November 2017

Flepp M

2

1 reference

26 November 2017

Sudre P

3

1 reference

26 November 2017

Furrer H

4

1 reference

26 November 2017

Haensel A

5

1 reference

26 November 2017

Hirschel B

6

1 reference

26 November 2017

Boggian K

7

1 reference

26 November 2017

Chave JP

8

1 reference

26 November 2017

Bernasconi E

9

1 reference

26 November 2017

Opravil M

11

1 reference

26 November 2017

Rickenbach M

12

1 reference

26 November 2017

Francioli P

13

1 reference

26 November 2017

Telenti A

14

1 reference

26 November 2017

language of work or name

English

0 references

publication date

23 October 2001

1 reference

Clinical Infectious Diseases

26 November 2017

1 reference

26 November 2017

33

1 reference

26 November 2017

11

1 reference

26 November 2017

1931-1937

1 reference

Fulminant hepatic failure associated with 2',3'-dideoxyinosine (ddI)

26 November 2017

1 reference

Fulminant hepatitis with severe lactate acidosis in HIV-infected patients on didanosine therapy

21 January 2018

1 reference

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

21 January 2018

1 reference

Steatosis-lactic acidosis syndrome associated with stavudine and lamivudine therapy

21 January 2018

1 reference

Lactic acidosis associated with stavudine administration: a report of five cases

21 January 2018

1 reference

Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy

21 January 2018

1 reference

Mitochondrial myopathy caused by long-term zidovudine therapy

21 January 2018

1 reference

Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea

21 January 2018

1 reference

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

21 January 2018

1 reference

Mitochondrial toxicity of antiviral drugs

21 January 2018

1 reference

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

21 January 2018

1 reference

Mitochondrial respiratory chain disorders I: mitochondrial DNA defects

21 January 2018

1 reference

Differential effects of antiretroviral nucleoside analogs on mitochondrial function in HepG2 cells

21 January 2018

1 reference

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy

21 January 2018

1 reference

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

21 January 2018

1 reference

AZT treatment induces molecular and ultrastructural oxidative damage to muscle mitochondria. Prevention by antioxidant vitamins

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/324353

1 reference

26 November 2017

1 reference